Sterling Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.67K Buy
262
+146
+126% +$2.05K ﹤0.01% 2679
2025
Q1
$1.81K Buy
116
+8
+7% +$125 ﹤0.01% 2629
2024
Q4
$1.5K Hold
108
﹤0.01% 2851
2024
Q3
$1K Buy
+108
New +$1K ﹤0.01% 2527